These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19521275)

  • 21. Involvement of bone marrow with intravascular large B-cell lymphoma.
    Sajid RM; Qureshi A
    Hematol Oncol Stem Cell Ther; 2010; 3(1):39-41. PubMed ID: 20231812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease.
    Hodges GF; Lenhardt TM; Cotelingam JD
    Am J Clin Pathol; 1994 Mar; 101(3):305-11. PubMed ID: 8135186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subtle bone marrow involvement by large B-cell lymphoma with pronormoblast-like morphology and prominent but not exclusive sinusoidal distribution.
    Roth CG; Reichard KK
    Am J Blood Res; 2012; 2(2):113-8. PubMed ID: 22762030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
    Suzuki M; Muroi A; Nojima M; Numata A; Takasaki H; Sakai R; Yokose T; Miyagi Y; Koshikawa N
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900091. PubMed ID: 31721454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinicopathological features of Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly].
    Xu FP; Liu YH; Zhuang HG; Luo DL; Li L; Zhang F; Luo XL; Du X; Li WY; Chen Q
    Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):616-21. PubMed ID: 22177246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epstein-Barr Virus-Positive CD20- and CD45-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic Challenge.
    Starr A; Kwon DH; Kallakury B
    Int J Surg Pathol; 2019 Feb; 27(1):98-101. PubMed ID: 29968492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffuse large B-cell lymphoma with distinctive patterns of splenic and bone marrow involvement: clinicopathologic features of two cases.
    Morice WG; Rodriguez FJ; Hoyer JD; Kurtin PJ
    Mod Pathol; 2005 Apr; 18(4):495-502. PubMed ID: 15492760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].
    Wang L; Wang W; Li X; Guo Y; Zhu X
    Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):307-12. PubMed ID: 25030862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography.
    Saiki Y; Tomita N; Uchida A; Uemura Y; Suzuki Y; Hirakawa T; Kato M; Hoshikawa M; Kawano T; Nakamura N; Miura I; Arai A
    Int J Hematol; 2021 May; 113(5):675-681. PubMed ID: 33515158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
    AbdullGaffar B; Seliem RM
    Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow flow cytometry in staging of patients with B-cell non-Hodgkin lymphoma.
    Kim B; Lee ST; Kim HJ; Kim SH
    Ann Lab Med; 2015 Mar; 35(2):187-93. PubMed ID: 25729719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
    Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
    Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T
    Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical role of flow cytometry in redefining bone marrow involvement in diffuse large B-cell lymphoma (DLBCL) - a new perspective.
    Talaulikar D; Shadbolt B; Bell J; Khan K; Dahlstrom JE; McDonald A; Pidcock M; Broomfield A
    Histopathology; 2008 Feb; 52(3):340-7. PubMed ID: 18269585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma.
    Jauw YW; Zijlstra JM; de Jong D; Vugts DJ; Zweegman S; Hoekstra OS; van Dongen GA; Huisman MC
    PLoS One; 2017; 12(1):e0169828. PubMed ID: 28060891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow involvement in T-cell-rich B-cell lymphoma.
    Skinnider BF; Connors JM; Gascoyne RD
    Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of CD20 alone could be misleading in lineage determination of B-cell lymphomas: a case of CD20 negative diffuse large B-cell lymphoma in abdominal effusion.
    Hoeller S; Tzankov A; Feichter G; Obermann E; Dirnhofer S
    Cytopathology; 2009 Aug; 20(4):273-4. PubMed ID: 19207312
    [No Abstract]   [Full Text] [Related]  

  • 40. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.
    Beltran B; Castillo J; Salas R; Quiñones P; Morales D; Hurtado F; Riva L; Winer E
    J Hematol Oncol; 2009 Feb; 2():11. PubMed ID: 19250532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.